论文部分内容阅读
近年来,我们应用多巴胺与654—2联合静脉滴注治疗慢性肺原性心脏病(简称肺心病)难治性心衰48例,疗效满意,报道如下。临床资料本组48例,系对我院1989年1月~1991年1月收治的符合全国1982年修定的肺心病诊断标准的134例肺心病患者,先行充分休息、吸氧、限盐、通畅呼吸道,抗感染,维持酸碱及电解质平衡,强心利尿等常规治疗2周,心功能仍为Ⅳ级(NYHA分类标准),定为难治性心衰患者。男27例,女21例。年龄38岁~74岁,平均58.9岁。病
In recent years, we use dopamine and intravenous infusion of 654-2 intravenous treatment of chronic pulmonary heart disease (referred to as pulmonary heart disease) refractory heart failure in 48 cases, with satisfactory results reported below. Clinical data The group of 48 cases, Department of our hospital from January 1989 to January 1991 admitted to meet the national diagnostic criteria for pulmonary heart disease in 1982 revised 134 cases of patients with pulmonary heart disease, the first full rest, oxygen, salt restriction, Smooth breathing, anti-infection, maintenance of acid-base and electrolyte balance, cardiac diuretic and other conventional treatment for 2 weeks, cardiac function is still Ⅳ level (NYHA classification), as refractory heart failure patients. There were 27 males and 21 females. Aged 38 years old to 74 years old, with an average of 58.9 years old. disease